BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1645723)

  • 1. Characterization of an extended form of recombinant human insulin-like growth factor II.
    Hammarberg B; Tally M; Samuelsson E; Wadensten H; Holmgren E; Hartmanis M; Hall K; Uhlén M; Moks T
    J Biol Chem; 1991 Jun; 266(17):11058-62. PubMed ID: 1645723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of recombinant human insulin-like growth factor II (IGF-II) expressed as a secreted fusion protein in Escherichia coli.
    Wadensten H; Ekebacke A; Hammarberg B; Holmgren E; Kalderén C; Tally M; Moks T; Uhlén M; Josephson S; Hartmanis M
    Biotechnol Appl Biochem; 1991 Jun; 13(3):412-21. PubMed ID: 1883532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of an insulin-like growth factor II variant from human plasma.
    Hampton B; Burgess WH; Marshak DR; Cullen KJ; Perdue JF
    J Biol Chem; 1989 Nov; 264(32):19155-60. PubMed ID: 2553732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutants of human insulin-like growth factor II (IGF II). Expression and characterization of truncated IGF II and of two naturally occurring variants.
    Lüthi C; Roth BV; Humbel RE
    Eur J Biochem; 1992 Apr; 205(2):483-90. PubMed ID: 1374027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells.
    Cohen P; Peehl DM; Lamson G; Rosenfeld RG
    J Clin Endocrinol Metab; 1991 Aug; 73(2):401-7. PubMed ID: 1713219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual affinity fusion approach and its use to express recombinant human insulin-like growth factor II.
    Hammarberg B; Nygren PA; Holmgren E; Elmblad A; Tally M; Hellman U; Moks T; Uhlén M
    Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4367-71. PubMed ID: 2543972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separation and characterization of modified variants of recombinant human insulin-like growth factor I derived from a fusion protein secreted from Escherichia coli.
    Forsberg G; Palm G; Ekebacke A; Josephson S; Hartmanis M
    Biochem J; 1990 Oct; 271(2):357-63. PubMed ID: 2173560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutants of human insulin-like growth factor II: expression and characterization of analogs with a substitution of TYR27 and/or a deletion of residues 62-67.
    Roth BV; Bürgisser DM; Lüthi C; Humbel RE
    Biochem Biophys Res Commun; 1991 Dec; 181(2):907-14. PubMed ID: 1721812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The design, expression, and characterization of human insulin-like growth factor II (IGF-II) mutants specific for either the IGF-II/cation-independent mannose 6-phosphate receptor or IGF-I receptor.
    Sakano K; Enjoh T; Numata F; Fujiwara H; Marumoto Y; Higashihashi N; Sato Y; Perdue JF; Fujita-Yamaguchi Y
    J Biol Chem; 1991 Nov; 266(31):20626-35. PubMed ID: 1657932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutants of human insulin-like growth factor II with altered affinities for the type 1 and type 2 insulin-like growth factor receptor.
    Bürgisser DM; Roth BV; Giger R; Lüthi C; Weigl S; Zarn J; Humbel RE
    J Biol Chem; 1991 Jan; 266(2):1029-33. PubMed ID: 1845984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of biologically active recombinant tilapia insulin-like growth factor-II polypeptides in Escherichia coli cells and characterization of the genomic structure of the coding region.
    Chen JY; Chang CY; Chen JC; Shen SC; Wu JL
    DNA Cell Biol; 1997 Jul; 16(7):883-92. PubMed ID: 9260931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression and characterization of human recombinant proinsulin-like growth factor II and a mutant that is defective in the O-glycosylation of its E domain.
    Yang CQ; Zhan X; Hu X; Kondepudi A; Perdue JF
    Endocrinology; 1996 Jul; 137(7):2766-73. PubMed ID: 8770896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor II binding to the type I somatomedin receptor. Evidence for two high affinity binding sites.
    Casella SJ; Han VK; D'Ercole AJ; Svoboda ME; Van Wyk JJ
    J Biol Chem; 1986 Jul; 261(20):9268-73. PubMed ID: 3013881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding specificities and transducing function of the different molecular weight forms of insulin-like growth factor-II (IGF-II) on IGF-I receptors.
    Perdue JF; LeBon TR; Kato J; Hampton B; Fujita-Yamaguchi Y
    Endocrinology; 1991 Dec; 129(6):3101-8. PubMed ID: 1659523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered affinity of insulin-like growth factor II (IGF-II) for receptors and IGF-binding proteins, resulting from limited modifications of the IGF-II molecule.
    Oh Y; Beukers MW; Pham HM; Smanik PA; Smith MC; Rosenfeld RG
    Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):249-54. PubMed ID: 1715685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning, characterization, and comparative activity of turbot IGF-I and IGF-II.
    Duval H; Rousseau K; Eliès G; Le Bail PY; Dufour S; Boeuf G; Boujard D
    Gen Comp Endocrinol; 2002 May; 126(3):269-78. PubMed ID: 12093114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factors (IGFs) reduce IGF-binding protein-4 (IGFBP-4) concentration and stimulate IGFBP-3 independently of IGF receptors in human fibroblasts and epidermal cells.
    Neely EK; Rosenfeld RG
    Endocrinology; 1992 Feb; 130(2):985-93. PubMed ID: 1370799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression, purification, and in vitro characterization of recombinant salmon insulin-like growth factor-II.
    Wilkinson RJ; Elliott P; Carragher JF; Francis G
    Protein Expr Purif; 2004 Jun; 35(2):334-43. PubMed ID: 15135411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of the insulin-like growth factor II binding site to amino acids 1508-1566 in repeat 11 of the mannose 6-phosphate/insulin-like growth factor II receptor.
    Schmidt B; Kiecke-Siemsen C; Waheed A; Braulke T; von Figura K
    J Biol Chem; 1995 Jun; 270(25):14975-82. PubMed ID: 7797478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a single cleavage in insulin-like growth factors I and II on binding to receptors, carrier proteins and antibodies.
    Jansen J; van Buul-Offers SC; Hoogerbrugge CM; Van Den Brande JL
    Biochem J; 1990 Mar; 266(2):513-20. PubMed ID: 2156497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.